Skip to main content

Inside the market strategies of today's drugmakers

Patent protection will run out later this decade for many multibillion-dollar medicines and will force their large pharmaceutical makers to find new products and markets. Explore some of the most important trends shaping the largest drugmakers’ market strategies in this Trendline.

included in this trendline
  • AbbVie tries to reassure investors on Humira biosimilar threat
  • New postpartum depression drugs are here. Diagnosis, treatment hurdles still stand in the way.
  • Biogen to invest more in launch of Alzheimer’s drug Leqembi
Our Trendlines go deep on the biggest trends. These special reports, produced by our team of award-winning journalists, help business leaders understand how their industries are changing.
Davide Savenije Editor-in-Chief at Industry Dive.